What It Is:

MedAff Catalyst organizes core scientific content into modular assets that can be deployed across advisory boards, medical education programs, field resources, congress activities, and digital channels while maintaining consistency, quality, and compliance.

Why It Matters:

In an environment of growing scientific complexity and expanding communication channels, MedAff Catalyst provides a structured framework that helps Medical Affairs teams coordinate scientific engagement efficiently, accelerate speed to launch, and maintain consistency across initiatives.

How It Works:

MedAff Catalyst begins by establishing a clear scientific foundation for engagement. From there, modular capabilities are activated to support advisory engagement, stakeholder insight generation, medical education, field enablement, and omnichannel communications.

Discover how MedAff Catalyst can be deployed for your organization.


The Latest

  • Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes
    Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes

    At Patients as Partners 2026, CEO Cheryl Lubbert shared how sustaining patient engagement through organizational change requires intentional design, with systems built to hold as teams, priorities, and programs shift.

  • Pharma USA 2026: AI Scales Reach in Pharma. But What Actually Changes Patient and HCP Behavior?
    Pharma USA 2026: AI Scales Reach in Pharma. But What Actually Changes Patient and HCP Behavior?

    AI is becoming a baseline expectation in pharma. At Pharma USA 2026, discussions reflected less focus on whether AI should be used and more on how it is being applied…

  • Approval Is Not the Finish Line: Turning Late-Stage Clinical Evidence Into Real-World Impact
    Approval Is Not the Finish Line: Turning Late-Stage Clinical Evidence Into Real-World Impact

    Late-stage clinical programs establish the evidence required for regulatory evaluation, but they do not guarantee adoption, access, or commercial performance. Translating that evidence into real-world impact requires patient-centered execution and…